April 27, 2018 3:38 AM ET

Biotechnology

Company Overview of Tamir Biotechnology, Inc.

Key Executives for Tamir Biotechnology, Inc.

NameBoard RelationshipsTitleAge
Jamie Marie Sulley 14 RelationshipsCEO, President, Secretary and Director51
Joanne M. Barsa No RelationshipsChief Financial Officer and Secretary55
Michele Carbone M.D., Ph.D.No RelationshipsChairman of the Thoracic Cancer Advisory Board--
Tommy G. Thompson 224 RelationshipsSpecial Advisor to Chief Executive Officer75

Tamir Biotechnology, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David Sidransky 103 RelationshipsIsrael Biotech Fund57
Jamie Marie Sulley 14 RelationshipsTamir Biotechnology, Inc.51
Paul M. K. Weiss 80 RelationshipsProCertus BioPharm, Inc.60
John P. Brancaccio 63 RelationshipsAccelerated Technologies, Inc.69
Stephen K. Carter M.D. 22 RelationshipsAllos Therapeutics, Inc.78
View All Board Members

Tamir Biotechnology, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee John P. Brancaccio63 Relationships3 Executives
Compensation Committee John P. Brancaccio63 Relationships2 Executives
Nominating Committee David Sidransky103 Relationships2 Executives
Corporate Governance Committee David Sidransky103 Relationships2 Executives
Advisory Board David Sidransky103 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.5K
Bonus
257.6K
Total Short Term Compensation
383.0K
Total Value of Options
5.2M
Compensation as of Fiscal Year
Tamir Biotechnology, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018
April 23, 2018 9:01 PM ET
Nohla Therapeutics Appoints Gary Christianson as Chief Operating Officer
April 23, 2018 8:00 PM ET
OrphoMed, Inc. Announces Management Changes
April 23, 2018 12:31 PM ET
Alder Biopharmaceuticals, Inc. Appoints Eric Carter as Interim Chief Medical Officer
April 23, 2018 12:30 PM ET
Advaxis, Inc Announces Management Changes
April 23, 2018 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tamir Biotechnology, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.